Browse by Journal Title

Group by: Date | Item Type

2023

Generation of an NCS1 gene knockout human induced pluripotent stem cell line using CRISPR/Cas9.
Maierhof, S.K. and Schinke, C. and Cernoch, J. and Hew, L. and Bruske, L.P. and Fernandez Vallone, V. and Fischer, K. and Stachelscheid, H. and Huehnchen, P. and Endres, M. and Diecke, S. and Telugu, N.S. and Boehmerle, W.
Stem Cell Research 73 : 103253. December 2023

Generation of iPSC lines with SLC16A2:G401R or SLC16A2 knock out.
Ludwik, K.A. and Opitz, R. and Jyrch, S. and Megges, M. and Weiner, J. and Beule, D. and Kühnen, P. and Stachelscheid, H.
Stem Cell Research 73 : 103256. 21 November 2023

Generation of an induced pluripotent stem cell line from a Huntington's disease patient with a long HTT-PolyQ sequence.
Miller, D.C. and Lisowski, P. and Genehr, C. and Wanker, E.E. and Priller, J. and Prigione, A. and Diecke, S.
Stem Cell Research 68 : 103056. April 2023

Generation of induced pluripotent stem cells from three individuals with Huntington's disease.
Miller, D.C. and Lisowski, P. and Lickfett, S. and Mlody, B. and Bünning, M. and Genehr, C. and Ulrich, C. and Wanker, E.E. and Diecke, S. and Priller, J. and Prigione, A.
Stem Cell Research 65 : 102976. December 2022

Generation of four iPSC lines from four patients with Leigh syndrome carrying homoplasmic mutations m.8993T > G or m.8993T > C in the mitochondrial gene MT-ATP6.
Lorenz, C. and Zink, A. and Henke, M.T. and Staege, S. and Mlody, B. and Bünning, M. and Wanker, E. and Diecke, S. and Schuelke, M. and Prigione, A.
Stem Cell Research 61 : 102742. May 2022

Generation of bi-allelic MYBPC3 truncating mutant and isogenic control from an iPSC line of a patient with hypertrophic cardiomyopathy.
Warnecke, N. and Ulmer, B.M. and Laufer, S.D. and Shibamiya, A. and Krämer, E. and Neuber, C. and Hanke, S. and Behrens, C. and Loos, M. and Münch, J. and Kühnisch, J. and Klaassen, S. and Eschenhagen, T. and Patten-Hamel, M. and Carrier, L. and Mearini, G.
Stem Cell Research 55 : 102489. August 2021

Generation of 20 human induced pluripotent stem cell lines from patients with focal segmental glomerulosclerosis (FSGS).
Cernoch, J. and Fisch, T. and Fischer, I. and Fischer, K. and Iwanska, A. and Krüger, N. and Küchler, J. and Schaar, C. and Schommer, S. and Telugu, N. and Miller, D. and Fernández Vallone, V. and Kurtz, A. and Reinke, P. and Diecke, S. and Stachelscheid, H.
Stem Cell Research 54 : 102406. July 2021

Cores laboratories: organization for stem cell technology advancement.
Dahéron, L. and Diecke, S. and Healy, L. and D'Souza, S.
Stem Cell Research 53 : 102266. May 2021

Generation of human induced pluripotent stem cells (EURACi001-A, EURACi002-A, EURACi003-A) from peripheral blood mononuclear cells of three patients carrying mutations in the CAV3 gene.
Meraviglia, V. and Benzoni, P. and Landi, S. and Murano, C. and Langione, M. and Motta, B.M. and Baratto, S. and Silipigni, R. and Di Segni, M. and Pramstaller, P.P. and DiFrancesco, D. and Gazzerro, E. and Barbuti, A. and Rossini, A.
Stem Cell Research 27 : 25-29. March 2018

Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
Fatima, A. and Ivanyuk, D. and Herms, S. and Heilmann-Heimbach, S. and O'Shea, O. and Chapman, C. and Izsvák, Z. and Farr, M. and Hescheler, J. and Šarić, T.
Stem Cell Research 16 (2): 304-307. March 2016

This list was generated on Thu Apr 25 02:33:05 2024 CEST.